Safety and Antibody Response After 1 and 2 Doses of BNT162b2 mRNA Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant

被引:55
作者
Le Bourgeois, Amandine [1 ]
Coste-Burel, Marianne [2 ]
Guillaume, Thierry [1 ,3 ]
Peterlin, Pierre [1 ]
Garnier, Alice [1 ]
Bene, Marie C. [3 ,4 ]
Chevallier, Patrice [1 ,3 ]
机构
[1] Nantes Univ Hosp, Dept Hematol, Nantes, France
[2] Nantes Univ Hosp, Dept Virol, Nantes, France
[3] Univ Nantes, Ctr Rech Cancerol & Immunol Nantes, Angers Inst Rech Sante, Inst Natl Sante & Rech Med,Unite Mixte Rech 1232, Nantes, France
[4] Nantes Univ Hosp, Hematol Biol, Nantes, France
关键词
D O I
10.1001/jamanetworkopen.2021.26344
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:4
相关论文
共 6 条
[1]   Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors [J].
Barriere, J. ;
Chamorey, E. ;
Adjtoutah, Z. ;
Castelnau, O. ;
Mahamat, A. ;
Marco, S. ;
Petit, E. ;
Leysalle, A. ;
Raimondi, V. ;
Carles, M. .
ANNALS OF ONCOLOGY, 2021, 32 (08) :1053-1055
[2]   Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients [J].
Boyarsky, Brian J. ;
Werbel, William A. ;
Avery, Robin K. ;
Tobian, Aaron A. R. ;
Massie, Allan B. ;
Segev, Dorry L. ;
Garonzik-Wang, Jacqueline M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (21) :2204-2206
[3]   Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study [J].
Garcia-Suarez, Julio ;
de la Cruz, Javier ;
Cedillo, Angel ;
Llamas, Pilar ;
Duarte, Rafael ;
Jimenez-Yuste, Victor ;
Hernandez-Rivas, Jose Angel ;
Gil-Manso, Rodrigo ;
Kwon, Mi ;
Sanchez-Godoy, Pedro ;
Martinez-Barranco, Pilar ;
Colas-Lahuerta, Blanca ;
Herrera, Pilar ;
Benito-Parra, Laurentino ;
Alegre, Adrian ;
Velasco, Alberto ;
Matilla, Arturo ;
Alaez-Uson, Maria Concepcion ;
Martos-Martinez, Rafael ;
Martinez-Chamorro, Carmen ;
Susana-Quiroz, Keina ;
Del Campo, Juan Francisco ;
de la Fuente, Adolfo ;
Herraez, Regina ;
Pascual, Adriana ;
Gomez, Elvira ;
Perez-Oteyza, Jaime ;
Ruiz, Elena ;
Alonso, Arancha ;
Gonzalez-Medina, Jose ;
Martin-Buitrago, Lucia Nunez ;
Canales, Miguel ;
Gonzalez-Gascon, Isabel ;
Vicente-Ayuso, Maria Carmen ;
Valenciano, Susana ;
Roa, Maria Garcia ;
Monteliu, Pablo Estival ;
Lopez-Jimenez, Javier ;
Escobar, Cristian Escolano ;
Ortiz-Martin, Javier ;
Diez-Martin, Jose Luis ;
Martinez-Lopez, Joaquin .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
[4]  
Le Bourgeois A., 2021, EJHAEM 0601
[5]   Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates [J].
Walsh, Edward E. ;
Frenck, Robert W., Jr. ;
Falsey, Ann R. ;
Kitchin, Nicholas ;
Absalon, Judith ;
Gurtman, Alejandra ;
Lockhart, Stephen ;
Neuzil, Kathleen ;
Mulligan, Mark J. ;
Bailey, Ruth ;
Swanson, Kena A. ;
Li, Ping ;
Koury, Kenneth ;
Kalina, Warren ;
Cooper, David ;
Fontes-Garfias, Camila ;
Shi, Pei-Yong ;
Tuereci, Oezlem ;
Tompkins, Kristin R. ;
Lyke, Kirsten E. ;
Raabe, Vanessa ;
Dormitzer, Philip R. ;
Jansen, Kathrin U. ;
Sahin, Ugur ;
Gruber, William C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25) :2439-2450
[6]   Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Societe Francophone de Greffe de Moelle et de Therapie cellulaire (SFGM-TC) multicentre cohort study [J].
Xhaard, Alienor ;
Xhaard, Constance ;
D'Aveni, Maud ;
Salvator, Helene ;
Chabi, Marie-Laure ;
Berceanu, Ana ;
Coman, Tereza ;
Beguin, Yves ;
Chalandon, Yves ;
Poire, Xavier ;
Loschi, Michael ;
Paillard, Catherine ;
Bruno, Benedicte ;
Ceballos, Patrice ;
Dalle, Jean-Hugues ;
Bilger, Karin ;
Bay, Jacques-Olivier ;
Robin, Marie ;
N'Guyen-Quoc, Stephanie ;
Rubio, Marie-Therese .
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (05) :E121-E124